Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03802721 · ClinicalTrials.gov registry record · Early Phase 1
Pharmacokinetics of Benzo[a]Pyrene: Impact of Diet
A Early Phase 1 study, sponsored by Oregon State University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 7
- Enrollment target
NCT03802721 is a Early Phase 1 study that has completed, run by Oregon State University. The registered enrollment target is 7 participants.
The verdict
NCT03802721, a Early Phase 1 study, has completed, sponsored by Oregon State University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
Evaluation of the pharmacokinetics for \[14C\]-benzo\[a\]pyrene (\[14C\]-BaP) and metabolites in plasma and urine over 48 hours following a 50 ng dose (5.4 nCi) alone, following 7 days' consumption of Brussels sprouts, and following 7 days' consumption of a supplement containing 3,3'-diindolylmethane (DIM).
Interventions
- DRUG [14C]-benzo[a]pyrene
- DRUG Brussels sprouts before 50 ng dose
- DRUG DIM supplement before 50 ng dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-01-24 |
| Est. Completion | 2024-02-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03802721
The ClinicalTrials.gov registry entry for NCT03802721 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon State University, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which [14C]-benzo[a]pyrene is the first listed.
NCT03802721 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03802721 about?
NCT03802721 is a clinical study titled "Pharmacokinetics of Benzo[a]Pyrene: Impact of Diet". Evaluation of the pharmacokinetics for \[14C\]-benzo\[a\]pyrene (\[14C\]-BaP) and metabolites in plasma and urine over 48 hours following a 50 ng dose (5.4 nCi) alone, following 7 days' consumption of Brussels sprouts, and following 7 days' consumption of a supplement containing 3,3'-diindolylmethan...
What is the current status of trial NCT03802721?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 7 participants. The study started on 2019-01-24. Estimated completion is 2024-02-01.
What interventions are being tested in trial NCT03802721?
The interventions under investigation include: [14C]-benzo[a]pyrene (DRUG), Brussels sprouts before 50 ng dose (DRUG), DIM supplement before 50 ng dose (DRUG).
Who is sponsoring clinical trial NCT03802721?
This trial is sponsored by Oregon State University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.